KCL CfAD (@kclcfad) profile picture

Interested in hearing about future research opportunities? Sign up to our participant database here: https://nitter.cf/t.co/2ecyVURfZg

London, England
Joined December 2016
Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)Photo by KCL CfAD (@kclcfad)
We are pleased to be in Milan attending the International Society for Affective Disorders (ISAD) 2023 @TCleare and Professor Allan Young opened the conference with the theme this year being ‘Redefining Treatment Paradigms in Mood Disorders’ #ISAD2023 – at Milan, Lombardy
1
2
8
1,621
We're back. The Centre for Affective Disorders at KCL is one of the UK's leading centres for research into depression, anxiety and related conditions, with a focus on improving treatments and patient outcomes. Follow us for updates on research, studies and events.
1
1
3
102
Interested in hearing about future research opportunities? Sign up to our participant database here: qualtrics.kcl.ac.uk/jfe/form…
1
41
Follow us for updates on research, publications, studies and events. You can also find us on: • Instagram: Centreforaffectivedisorders • Facebook: Centre for Affective Disorders • LinkedIn: Centre for Affective Disorders (CfAD) #MentalHealthResearch #ClinicalResearch
1
34
Published today in Lancet Psychiatry, after 7 years of hard labour... the first long-term head-to-head comparison of two augmentation treatments in treatment resistant depression. Clinical and cost-effectiveness of lithium versus quetiapine augmentat... sciencedirect.com/science/ar…
9
30
5
121
16,775
Fantastic setting for a conference in Milan, and (if I do say so myself) a wonderful academic event! See you for ISAD2024 and 2025! @ISADTweet
It is the final day of the affective disorders conference #ISAD2023 This afternoon we look forward to more talks exploring Anhedonia, Specificity vs NonSpecificity and the heterogeneity of depression and Antiglutamatergic Therapy As well as the upcoming career awards 🏆
1
8
468
@kclcfad CRiB2 researchers @kalfas_michael and @Rosie_H_Taylor presented preliminary findings regarding the discrepancy between subjective and objective reports of cognitive performance at #ISAD2023 The implications for cognitive remediation therapy were discussed – at Milan, Lombardy
3
8
1,630
Francesca Bentivegna reported from #ISAD2023 for @Mental_Elf with vigour and dedication (thank you so much!) as well as presenting her own interesting findings (from @UCL_IOE_PHD and @CUBIC_UCL): Trajectories of Self-Regulation in Childhood and Reward Processing in Adolescence – at Milan, Lombardy
3
3
1
9
2,520
It is well worth zooming in to the results, they are very interesting Other authors: Eirini Flouri, Steven Papachristou – at Milan, Lombardy
3
143
A wonderful poster (take a closer look at the infographics!) of a systematic review from the @kclcfad team The Effects of single dose and repeated dose of Ketamine on cognition in Treatment-Resistant Depression Fatema Alhayyas, @Laithalexander and @MarioJuruena #ISAD2023 – at Milan, Lombardy
2
6
977
3) Dr Clare Dolman @dolman_clare – Patient Advocate Award 🏆 #ISAD2023
1
2
3
268
1) Dr Rebecca Strawbridge @Strawbr1 – Early Career Award Winner 🏆 #ISAD2023
1
2
1
8
1,200
The time to say bye has come, as the Closing Ceremony took place at #ISAD2023! But first, @ISADTweet President Prof @TCleare gave the prizes 🏆 to the Award winners for their outstanding work. Long applauses followed for the awardees – huge congrats everyone! 👏👏👏 THREAD 👇
2
1
7
2,075
Find out all about #ketamine treatment in #ISAD2023 Symposium 10, chaired by CfAD expert Dr @MarioJuruena. “Antiglutamatergic Therapy in Difficult to Treat #depression and #bipolar Disorder", with exciting talks by Mario, Prof @mehta_mitul72 and Prof Machado-Vieira. 🧵 THREAD
4
1
5
2,823
What predicts antidepressant response to #ketamine ? Prof Rodrigo Machado-Vieira's outstanding presentation spans from clinical variables (BMI, family Hx of ETOH abuse) to biomarkers (D-serine, BDNF, adipokines...) What do you think is the strongest predictor? 💉💊 #ISAD2023
1
1
191
Prof Allan Young and Prof Eric Ruhe join the discussion: which ketamine admin route is the fastest? the most cost-effective? the most effective on suicidal ideation? #ISAD2023 @ISADTweet
1
170
The conference is soon to end… but first, Luca Sforzini @_Luca_Sforzini has just made an important closing point about the diverse terminology and assessments for a single construct during his talk on a Delphi-method-based consensus guideline for definition of TRD #ISAD2023 – at Milan, Lombardy
1
3
5
893
The chair Brenda Penninx @brenda_penninx asks would TRD be better described as ‘medication treatment resistant depression’ @_Luca_Sforzini agrees although highlights how difficult it is to standardise psychotherapy and draw clear conclusions re mean response #ISAD2023 – at Milan, Lombardy
1
1
295
@MarioJuruena is the Lead Consultant at the Maudsley Advanced Treatment Service (MATS), providing cutting-edge treatments for complex #affectivedisorders, including subcutaneous #ketamine and neuromodulation techniques #ISAD2023
1
4
201
Anna Tröger (a @kclcfad PhD student) presents her poster, a meta-analysis and meta-regression reporting that: Baseline depression severity does not moderate the effects of psychotherapy compared with pharmacotherapy for depression. #ISAD2023 – at Milan, Lombardy
4
9
1,416
Fascinating talk by Prof @mehta_mitul72 on ketamine's #reward circuitry modulation 🧠 More research on ketamine and reward in #bipolar disorder is needed ‼️
3
103
Here is Jawaher S. Alnassar presenting her poster on ‘The impact of early life stress on adulthood personality traits.’ Other authors included @MarioJuruena @AdamPerkinsPhD and Professor Allan. H Young – at Milan, Lombardy
1
4
1,316